Biotech Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences May 15, 2025
Biotech Kaerus Bioscience’s lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS) May 14, 2025
Biotech Shamekh SIV Solutions Announces $5.8 Billion Global Pharmaceutical Manufacturing Plan May 14, 2025
Biotech Eligo Bioscience Awarded $5 Million to Advance Breakthrough Genetic Medicine Platform for Immuno-Dermatology May 13, 2025
Biotech Strategic Partnership | Sanyou Bio and TransRecoBio Forge Strategic Alliance to Build a New Ecosystem for the Full Industry Chain May 13, 2025
Biotech Alphyn Doses First Patients in CLEAR-AD1 Global Phase 2b Clinical Trial Program for Atopic Dermatitis May 12, 2025
Biotech Prof. Mike Chan’s Precision Medicine Vision Validated by Landmark Human Cytology Study Mapping Over 400 Distinct Cell Types – with Special Focus on the Brain May 12, 2025
Biotech Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS May 12, 2025
Biotech Skyline Therapeutics Presents Late-Breaking Abstract on SKG1108, a Novel Optogenetic Gene Therapy for Retinitis Pigmentosa, at ASGCT 2025 May 11, 2025
Biotech Anivive’s Dr. Edward Robb Presents Innovative Valley Fever Vaccine Research at World Vaccine Congress 2025 May 10, 2025
Search
Biotech
May 15, 2025
May 14, 2025
May 14, 2025
May 13, 2025
May 13, 2025
May 12, 2025
May 12, 2025
May 12, 2025
May 11, 2025
May 10, 2025
